Unique ID issued by UMIN | UMIN000042118 |
---|---|
Receipt number | R000048069 |
Scientific Title | Relationship between the pathogenesis of treatment-resistant depression and brain beta-amyloid: an exploratory study by measuring trace beta-amyloid levels in plasma |
Date of disclosure of the study information | 2020/11/01 |
Last modified on | 2020/10/14 15:25:51 |
Relationship between the pathogenesis of treatment-resistant depression and brain beta-amyloid: an exploratory study by measuring trace beta-amyloid levels in plasma
Relationship between the pathogenesis of treatment-resistant depression and brain beta-amyloid
Relationship between the pathogenesis of treatment-resistant depression and brain beta-amyloid: an exploratory study by measuring trace beta-amyloid levels in plasma
Relationship between the pathogenesis of treatment-resistant depression and brain beta-amyloid
Japan |
Depression
Psychiatry |
Others
NO
The purpose of this study is a basic exploratory study to explore the potential of anti-amyloid therapy for refractory depression. Brain A-beta accumulation in refractory depressed patients will be measured by quantitative plasma beta-amyloid (A-beta) assay and compared with data from age-specific healthy subjects. We will also examine the relationship between plasma A-beta and depression symptomatology and cognitive functions related to memory and organization in patients with refractory depression to determine the physiological role of A-beta in the brain of patients with depression.
Others
N/A
Differences in plasma A-beta40 and A-beta42 concentrations between depressed and healthy subjects
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Other |
Blood examinetion (plasma concentraton of beta amyloid)
20 | years-old | <= |
80 | years-old | >= |
Male and Female
-Patients who meet the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnostic criteria for major depressive disorder (depression).
-Patients between the ages of 20 and 80 years old at the time of participation in the study
-At least one antidepressant medication in a current or past depressive episode
-Patients who do not respond to sufficient doses and duration of pharmacotherapy to meet the
-Patients with other comorbid psychiatric disorders
-Patients with a history of neurological or cerebral organic disorders
-Patients with serious metabolic, endocrine and other physical diseases
-Patients with significant suicidal ideation
50
1st name | Fumitoshi |
Middle name | |
Last name | Kodaka |
The Jikei University School of Medicine
Department of Psychiatry
105-8471
3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8471, Japan
03-3433-1111
kodaka@jikei.ac.jp
1st name | Fumitoshi |
Middle name | |
Last name | Kodaka |
The Jikei University School of Medicine
Department of Psychiatry
105-8471
3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8471, Japan
03-3433-1111
kodaka@jikei.ac.jp
The Jikei University School of Medicine
The Jikei University School of Medicine
Other
The Jikei University School of Medicine
3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8471, Japan
03-3433-1111
kodaka@jikei.ac.jp
NO
2020 | Year | 11 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2019 | Year | 07 | Month | 08 | Day |
2019 | Year | 07 | Month | 08 | Day |
2020 | Year | 01 | Month | 01 | Day |
2021 | Year | 04 | Month | 30 | Day |
2020 | Year | 10 | Month | 14 | Day |
2020 | Year | 10 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048069